Estrella Immunopharma Inc...

NASDAQ: ESLA · Real-Time Price · USD
0.91
0.05 (5.76%)
At close: Aug 15, 2025, 3:59 PM
0.89
-1.70%
After-hours: Aug 15, 2025, 04:12 PM EDT

Estrella Immunopharma Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Dec 31, 2022 Jun 30, 2022
Cash & Equivalents
4.17M 40.8K 4.09M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a 9.67M 45.19M
Other Long-Term Assets
n/a n/a n/a
Receivables
288.76K n/a n/a
Inventory
n/a n/a n/a
Other Current Assets
n/a n/a n/a
Total Current Assets
4.45M 52.43K 4.92M
Property-Plant & Equipment
n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
n/a 9.93M 45.19M
Total Assets
4.45M 9.99M 4.92M
Account Payables
n/a 46.88K 945.59K
Deferred Revenue
n/a n/a n/a
Short-Term Debt
n/a 498.6K n/a
Other Current Liabilities
129.72K 8.79M n/a
Total Current Liabilities
180.7K 1.07M 946.68K
Long-Term Debt
n/a n/a n/a
Other Long-Term Liabilities
n/a 1.55M 5.01M
Total Long-Term Liabilities
n/a 1.84M 5.01M
Total Liabilities
180.7K 2.92M 5.96M
Total Debt
n/a 498.6K n/a
Common Stock
3.66K 9.33M 18.00
Retained Earnings
-19.5M -2.26M -1.07M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
4.27M 7.07M -1.04M
Total Investments
n/a 9.67M 45.19M